Trial
NCT00663910
Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
National Cancer Institute (NCI)
Condition
Non-melanomatous Skin Cancer
Intervention
Aminolevulinic Acid
Why stopped
Of the 8 histologically proven tumors, detection of PpIX proved to be ambiguous.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-02